outcome-switching

Randomized clinical trials are widely accepted as the gold standard approach to test new line of drugs, therapies, or treatments. They reduce bias by randomly allocating patients to either a treatment or a control group. In this scenario, variables other than the planned medical intervention remain constant between the two groups. This way any observed differences can be attributed to the treatment being tested. However, outcome switching is one of the fallacies of these clinical studies and impacts the regulatory approval decisions.


Open Access Ebook
10% off on Learn
So Close!
Call with our Experts
Get Featured on Site
15% off on Learn
No Luck Today
10% off on Consult
Almost!
Journal Selection Ebook
$100 Off on Editing
Unlucky
Spin to Win!
This is your chance to win amazing prizes and discounts on Enago Learn, Enago Consult, and English Editing Services.
Note: You can avail your coupon codes on the below pages:
  • English Editing - www.enago.com
  • Enago Learn - www.enago.com/learn
  • Enago Consult - consult.enago.com